-

Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Hawaii Afford Care They Require

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage

HONOLULU--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization commends Representative Lauren Matsuomto (R-Mililani) introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening.

The exorbitant out-of-pocket costs associated with this critical breast imaging, ranging from hundreds to thousands of dollars, often force individuals to make significant financial sacrifices or forego tests that can confirm or rule out cancer.

“Nobody should be forced to skip medical care that helps to detect breast cancer early because of the cost, yet thousands of Hawaiians are forced to make that decision every year,” said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen. “This bill will remove the financial barrier so that individuals can get the medically necessary breast imaging they need without having to endure financial burdens. This is a pivotal step toward reducing overall health care costs by enabling earlier detection, more timely treatment and better outcomes.”

Unfortunately, when a mammogram reveals an abnormality or an individual is at higher risk of breast cancer, diagnostic and supplemental imaging is required to complete their early detection process. HB 2366, introduced by Rep. Matsumoto, eliminates the patient’s out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging such as breast MRIs and ultrasounds.

"Breast cancer can devastate lives, families, and communities, but when it's diagnosed early, people are given a fighting chance at a healthy future.” said Rep. Matsumoto. “This legislation will ensure that cost is never a barrier to early breast cancer detection. I look forward to working alongside my colleagues to advance HB 2366."

A Komen-commissioned study found out-of-pockets costs for patients to range from $234 for a diagnostic mammogram to more than $1,000 for a breast MRI. Another recent study published in Radiology found that 1 in 5 patients said they would not go in for recommended follow-up imaging if they had to pay a deductible. By eliminating burdensome financial barriers to comprehensive preventive care, we can drive earlier detection, improve outcomes, reduce the overall costs to the health care system and create a healthier more productive workforce.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Amy Jo Steinbruecker
Susan G. Komen
972-701-2071
asteinbruecker@komen.org

Susan G. Komen


Release Versions

Contacts

Amy Jo Steinbruecker
Susan G. Komen
972-701-2071
asteinbruecker@komen.org

More News From Susan G. Komen

Breast Cancer 2026 Progress Outlook: New Research Discoveries and Opportunities

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today issued its 2026 Breast Cancer Progress Outlook. New data shows the U.S. breast cancer death rate has declined 44% between its peak in 1989 and 2023 — averting an estimated 546,000 deaths due largely to advances in treatment and earlier detection through screening. Yet breast cancer remains an urgent public health challenge. Incidence of invasive breast cancer has been rising since the mid-2000s, incr...

A Night to Remember: Susan G. Komen® and Trisha Yearwood Announce Star-Studded Lineup for The Second Annual "Band As One Nashville Concert for the Cure" at The Opry House

NASHVILLE, Tenn.--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, and country music icon Trisha Yearwood, today announced the confirmed line up for the second annual “Band As One Nashville Concert for the Cure: Trisha Yearwood & Friends” on March 22, 2026. This year’s event will celebrate those that have been impacted by breast cancer at a new location: The historic Opry House. Yearwood will return as the event headliner along with some of music’s most reco...

Legislation in Tennessee Seeks to Increase Access to Genetic Testing

NASHVILLE, Tenn.--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends Representative Rick Scarbrough (R-Oak Ridge) and Senator Richard Briggs (R-Knoxville) for introducing legislation that would eliminate financial barriers for patients requiring clinically appropriate genetic testing, as well as the recommended screenings based on the results of that testing. Germline testing is a type of test that looks for inherited mutations that have been present in e...
Back to Newsroom